Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Mydacla 60 mg Tablet
Manufacturer/Marketed By : Mylan Pharmaceuticals Pvt Ltd
$32.16 $11.61
Mydacla 60 mg tablet is a powerful antiviral medication specifically designed to combat chronic hepatitis C, a persistent viral infection affecting the liver in adults. Often prescribed in conjunction with...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Daclatasvir 60 mg
Active Pharmaceutical Ingredient
Mydacla 60 mg Tablet
32.16$
11.61$
Mydacla 60 mg tablet is a powerful antiviral medication specifically designed to combat chronic hepatitis C, a persistent viral infection affecting the liver in adults. Often prescribed in conjunction with other antiviral agents, particularly sofosbuvir and, in some cases, ribavirin, Mydacla works effectively to lower the levels of the hepatitis C virus in the body. By targeting the virus, this medication helps to manage the infection and may improve liver health over time. It is important to follow your healthcare provider's instructions carefully, as Mydacla is part of a comprehensive treatment plan tailored to your individual needs. Patients should be aware of potential side effects, including fatigue and headache, and report any unusual symptoms to their doctor promptly. As with any antiviral treatment, adherence to the prescribed regimen is crucial for optimal effectiveness and to reduce the risk of resistance. Always consult your healthcare professional before starting or stopping any medication, ensuring a safe and informed approach to your hepatitis C management.
Active Pharmaceutical Ingredient
Uses
• Mydacla 60 mg tablet is primarily indicated for the treatment of chronic hepatitis C infection. This ongoing viral infection poses a significant risk to liver health and can lead to serious complications. When used in combination with sofosbuvir, and optionally with ribavirin, Mydacla 60 mg tablet helps to target the hepatitis C virus effectively. It is suitable for adults with specific genotypes of the virus.
• The effectiveness of Mydacla 60 mg tablet extends to patients infected with hepatitis C virus genotype 1 and genotype • These genotypes represent common strains of the virus that can be particularly challenging to treat. By utilizing Mydacla 60 mg tablet in a comprehensive treatment regimen, healthcare providers aim to improve the likelihood of viral clearance. This targeted approach is essential for managing chronic infections.
• In clinical practice, Mydacla 60 mg tablet is often prescribed as part of a combination therapy regimen. This strategy enhances the overall effectiveness of the treatment plan, allowing for a more robust response against the hepatitis C virus. Patients typically benefit from this multi-drug approach, which includes Mydacla 60 mg tablet to maximize treatment outcomes. It is essential for healthcare professionals to assess each patient's unique circumstances to optimize therapy.
• Mydacla 60 mg tablet is an important option for adults seeking to manage their chronic hepatitis C infection. Its role in combination therapy highlights the importance of a comprehensive treatment approach to viral infections. As part of a coordinated care plan, Mydacla 60 mg tablet contributes to the overall goal of achieving sustained virologic response. This can lead to improved liver health and quality of life for affected individuals.
Benefits
Mydacla 60 mg Tablet has been shown to be effective in clearing the hepatitis C virus from the body in a high percentage of people. Mydacla for Hepatitis C Tablet may cause a low risk of side effects compared to some older treatments for hepatitis C. Daclatasvir 60 mg Tablet does not have the same dietary restrictions as some older treatments for hepatitis C, which can make it easier for patients to stick to their treatment regimen.
Side Effects
Mydacla 60 mg may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Tiredness
• Vomiting
• Headache
Common Side Effects
• Nausea
• Slower Rate of Heartbeat
• Liver Related Problems
• Body Pain
• Muscle Pain
How To Use
Mydacla for Hepatitis C Tablet may take with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Mydacla 60 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Mydacla 60 mg is safe to use in patients with kidney disease. No dose adjustment of Mydacla 60 mg is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Mydacla for Hepatitis C Tablet. Daclatasvir 60 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Mydacla 60 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Mydacla 60 mg Tablet is safe to use in patients with liver disease. No dose adjustment of Mydacla 60 mg Antiviral Tablet is recommended. If you experience any side effects, please consult your doctor.
• Pregnancy: Use of Daclatasvir 60 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Mydacla 60 mg Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Mydacla Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Mydacla 60 mg Antiviral Tablet.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.